China Aoxing Pharmaceutical Company released its financial report for its fiscal year, which ended June 30, 2008. The company’s revenues climbed 264% to $7 million, helped by a $2.7 million contribution from a new acquisition. Revenue growth from its own products was 123%. Gross profit totaled $2.3 million, representing a rise of 259%. Unfortunately, net income was a loss of $3.6 million on a non-GAAP basis. More details...

Stock Symbols: (NSDQ: CAXG) (NYSE: AOB)